Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AMG 655 or AMG 479 with Gemcitabine in Metastatic Pancreatic Cancer
NCT00630552Phase 2Completed
- Sponsor
- ImmunityBio, Inc.
- Start
- Jun 2007
- Primary completion
- Jan 2010
- Modality
- Recombinant Proteins and Enzymes, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of conatumumab, ganitumab, sponsored by ImmunityBio, Inc.. Started Jun 2007; status: completed.
02
Drugs
conatumumabganitumab
Beyond the preview
Go deeper on NCT00630552.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00630552.